首页> 美国卫生研究院文献>Current Controlled Trials in Cardiovascular Medicine >Neonatal resuscitation using a supraglottic airway device for improved mortality and morbidity outcomes in a low-income country: study protocol for a randomized trial
【2h】

Neonatal resuscitation using a supraglottic airway device for improved mortality and morbidity outcomes in a low-income country: study protocol for a randomized trial

机译:使用声门上气道装置进行新生儿复苏以改善低收入国家的死亡率和发病率:一项随机试验的研究方案

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundIntrapartum-related death is the third leading cause of under-5 mortality. Effective ventilation during neonatal resuscitation has the potential to reduce 40% of these deaths. Face-mask ventilation performed by midwives is globally the most common method of resuscitating neonates. It requires considerable operator skills and continuous training because of its complexity. The i-gel® is a cuffless supraglottic airway which is easy to insert and provides an efficient seal that prevents air leakage; it has the potential to enhance performance in neonatal resuscitation. A pilot study in Uganda demonstrated that midwives could safely resuscitate newborns with the i-gel® after a short training session. The aim of the present trial is to investigate whether the use of a cuffless supraglottic airway device compared with face-mask ventilation during neonatal resuscitation can reduce mortality and morbidity in asphyxiated neonates.
机译:背景产时相关死亡是5岁以下儿童死亡率的第三大诱因。新生儿复苏期间有效的通气有可能减少40%的此类死亡。全球范围内,助产士进行口罩通气是使新生儿复苏的最常见方法。由于其复杂性,它需要大量的操作员技能和持续的培训。 i-gel ®是一种无袖带的声门上气道,易于插入并提供有效的密封,可防止漏气。它具有增强新生儿复苏性能的潜力。在乌干达进行的一项初步研究表明,在进行短暂的训练后,助产士可以使用i-gel ®安全地复苏新生儿。本试验的目的是研究新生儿复苏时使用无袖囊声门上气道装置与面罩通气相比是否可以降低窒息新生儿的死亡率和发病率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号